张茜;史艳梅;李秀敏;苗明三;
ZHANG Xi;SHI Yan-mei;LI Xiu-min;MIAO Ming-san;Henan University of Chinese medicine;

• 1:河南中医药大学

摘要(Abstract)：

该文基于特应性皮炎(atopic dermatitis,AD)中西医临床病症特点,通过查阅近年来相关文献,总结已有的造模方法,对现有的动物模型进行分析,评价了模型与AD临床表现的吻合度及优缺点。通过发现自发型、转基因/基因敲除模型吻合度较高,但饲养条件要求高且价格昂贵;半抗原诱导模型造模成本低、速度快,在一定程度上揭示了AD的相应机制,但没有完全反应AD疾病全过程状态,且造模方法以西医为指导,缺乏中医致病因素,相关的中医证型模型存在缺失,在中医药研究上有一定的局限性。因此科研人员仍需结合AD中西医病因病机、临床表现,提高模型与临床病症特点的吻合度,为AD的深入研究设计合理的动物模型。
Based on the clinical characteristics of atopic dermatitis( AD) in traditional Chinese medicine( TCM) and Western medicine,the existing animal models were analyzed,and the coincidence degree,advantages and disadvantages between the models and the clinical manifestations of AD were evaluated,so as to provide reference for establishing a rational animal model. After consulting relevant literatures in recent years and summarizing the existing modeling methods,it is found that spontaneous,transgenic/gene knockout models were highly consistent,but with high breeding conditions and expensive prices. The hapten-induced model was low in cost and fast in modeling. It revealed the corresponding mechanism of AD to a certain extent,but did not fully reflect the state of the entire process of AD. The modeling method was guided by Western medicine,but with a lack of pathogenic factors of traditional Chinese medicine,and so has certain limitations in TCM research. Therefore,it is necessary to combine the etiology,pathogenesis and clinical mani-festations of AD with traditional Chinese and Western medicine,so as to improve the coincidence degree between the model and the characteristics of clinical symptoms and lay the foundation for in-depth studies on AD.

关键词(KeyWords)： 特应性皮炎;临床病症;动物模型
atopic dermatitis;clinical symptoms;animal model

Abstract:

Keywords:

基金项目(Foundation): 国家国际合作基地项目(2016-65);; 河南省杰出外籍科学家工作室项目(GZS2019006);; 中原学者项目(162101510003)

作者(Author): 张茜;史艳梅;李秀敏;苗明三;
ZHANG Xi;SHI Yan-mei;LI Xiu-min;MIAO Ming-san;Henan University of Chinese medicine;

Email:

DOI: 10.19540/j.cnki.cjcmm.20200916.604

参考文献(References)：

• [1]陈丽萍,黄晓燕,肖易,等.我国特应性皮炎、银屑病、痤疮和荨麻疹的患病率及危险因素[J].中南大学学报(医学版),2020,45(4):449.
• [2]王东明,丁佩军,马欣,等.清热祛湿方对丝聚合基因缺乏特应性皮炎样模型小鼠IL-33/ST2信号通路的影响[J].中华中医药杂志,2020,35(3):1493.
• [3]刘方方,王华.特应性皮炎的靶向治疗药物研究进展[J].儿科药学杂志,2019,25(11):55.
• [4]周蔓钰,左文慧,刘红霞.特应性皮炎与丝聚合蛋白基因的相关性研究[J].新疆中医药,2018,36(1):139.
• [5]卢静静,郑源泉,付桂莉.他克莫司软膏联合润肤剂治疗儿童特应性皮炎疗效观察[J].临床皮肤科杂志,2018,47(4):249.
• [6]尤艺璇,涂颖,刘海洋,等.青刺果油对特应性皮炎样小鼠模型表皮通透屏障及抗菌肽表达的影响[J].中国皮肤性病学杂志,2018,32(6):632.
• [7]郑益志,余土根,贾丽莹,等.特应性皮炎血清瘦素及白细胞介素-6水平与中医证型的相关性研究[J].中华中医药杂志,2013,28(12):3669.
• [8]郭静,肖敏,彭丽,等.艾儒棣从脾胃论治小儿特应性皮炎经验[J].中华中医药杂志,2017,32(8):3534.
• [9]刘俊峰,薛素琴,陈达灿.培土清心方对特应性皮炎患者血清n-6必需脂肪酸的影响[J].中国实验方剂学杂志,2013,19(3):292.
• [10]罗凤林,周沪程,刘莉萍,等.精神神经因素在特应性皮炎发生发展和预防中的作用[J].中国皮肤性病学杂志,2020,34(6):696.
• [11]李晨帅.任勤教授辨治儿童特应性皮炎临床经验[J].中医儿科杂志,2019,15(4):21.
• [12]中国特应性皮炎诊疗指南(2020版)[J].中华皮肤科杂志,2020,27(2):81.
• [13]李邻峰.特应性皮炎[M].北京:北京大学医学出版社,2006:54.
• [14]李迎,张吉林,宋玉国.特应性皮炎患者外周血microRNA-155和CD4+T细胞检测的临床意义[J].中国免疫学杂志,2015,31(12):1679.
• [15]高兴华,狄正鸿.特应性皮炎的病征管理[J].皮肤病与性病,2012,34(6):326.
• [16]慕彰磊,张建中.特应性皮炎的诊断标准[J].中国医学文摘(皮肤科学),2016,33(2):97.
• [17] GUO Y,ZHANG H,YAO Z,et al. Phenotypic analysis of atopic dermatitis in children aged 1-12 months:elaboration of novel diagnostic criteria for infants in China and estimation of prevalence[J]. J Eur Acad Dermatol Venereol,2019,33(8):1569.
• [18]田硕,曹利华,苗明三,等.基于临床中西医病症特点的中医药动物模型评价新方法[J].中药药理与临床,2017,33(6):165.
• [19]陈达灿.特应性皮炎中医诊疗方案专家共识[J].中国中西医结合皮肤性病学杂志,2013,12(1):60.
• [20]国家中医药管理局医政司.24个专业105个病种中医诊疗方案(试行)[S]. 2011.
• [21]王雄.基于免疫调节机制探讨龙牡汤对特应性皮炎小鼠模型的治疗作用[D].北京:中国中医科学院,2017.
• [22] YOO J,MANICONE A M,MCGUIRE J K,et al. Systemic sensitization with the protein allergen ovalbumin augments local sensitization in atopic dermatitis[J]. Inflamm Res,2014,7:29.
• [23]石慧娟,李嘉,任亚惠,等.局部外用CKLF1拮抗肽C19在小鼠特应性皮炎的治疗作用[J].临床和实验医学杂志,2018,17(7):677.
• [24]王雄,姚春海,刘青云,等.龙牡汤对特应性皮炎小鼠模型的TLR-4、NF-κB p65表达影响[J].中国中西医结合皮肤性病学杂志,2019,18(3):198.
• [25]王欣欣,李思佳,关洪全,等.DNCB对BALB/c小鼠特应性皮炎的诱导作用及其机制[J].吉林大学学报(医学版),2020,46(3):439.
• [26]莫俊銮,周继昌,刘小立,等.DNCB致敏诱导BALB/c小鼠特应性皮炎模型的建立[J].中国热带医学,2013,13(12):1439.
• [27]窦侠,刘小明,李子卓,等.粉尘螨诱导建立“特应性皮炎-哮喘”小鼠模型[J].中国皮肤性病学杂志,2018,32(3):275.
• [28] YEOM M,KIM S H,LEE B,et al. Oral administration of glucosylceramide ameliorates inflammatory dry-skin condition in chronic oxazolone-induced irritant contact dermatitis in the mouse ear[J]. J Dermatol Sci,2012,67(2):101.
• [29] CHAN L S,ROBINSON N,XU L. Expression of interleukin-4in the epi-dermis of transgenic mice results in a pruritic inflammatory skin disease:an experimental animal model to study atopic dermatitis[J]. J Invest Dermatol,2001,117(4):977.
• [30] TSUKUBA T,OKAMOTO K,OKAMOTO Y,et al. Association of cathepsin E deficiency with development of atopic dermatitis[J].J Biochem,2003,134(6):893.
• [31] TSUJI T,OKUNO S,KURODA A,et al. Therapeutic approach to mite-induced intractable dermatitis using novel immunomodulator FTY720 ointment(fingolimod)in NC/Nga mice[J]. Alergol Int,2016,65(2):172.
• [32]徐宏俊,赵琰,慕彰磊,等.嗜酸性粒细胞在MC903诱导小鼠特应性皮炎中的作用及机制初探[J].中国皮肤性病学杂志,2018,32(12):1367.
• [33]兰宇贞,慕彰磊,赵琰,等.外用苯烯莫德对特应性皮炎样小鼠的治疗作用[J].中国麻风皮肤病杂志,2018,34(8):468.
• [34]刘勇,赵一丁,闫小宁.中药健脾法治疗特应性皮炎的Meta分析[J].中国中药杂志,2018,43(9):1922.
• [35]刘方方,王华.特应性皮炎的靶向治疗药物研究进展[J].儿科药学杂志,2019,25(11):55.
• [36]施建林,王炜,江山,等.特应性皮炎影响量表的分析与应用[J].中国医疗美容,2020,10(3):111.